Literature DB >> 12490369

The effect of Pluronic on the protein release kinetics of an injectable drug delivery system.

J R DesNoyer1, A J McHugh.   

Abstract

A new class of injectable controlled release depots has been prepared by incorporating materials that preferentially segregate during phase inversion. These consist of blends of poly(ethylene oxide) (PEO)/poly(propylene oxide) (PPO)/poly(ethylene oxide) (PEO) triblock copolymers (Pluronics) with poly(D,L-lactide) (PDLA)/1-methyl-2-pyrrolidinone (NMP) solutions. The effects of preferential segregation on the phase inversion dynamics and in vitro protein release kinetics were examined using dark ground imaging, high performance liquid chromatography (HPLC), scanning electron microscopy (SEM), and confocal microscopy. Variations in Pluronic concentration and molecular weight had an insignificant effect on the internal depot morphologies, however, increasing the concentration and molecular weight did result in increased phase separation rates and, surprisingly, a decrease in the magnitude of the protein burst, though the release profiles still retained a typical burst-type shape. Additionally, increasing the Pluronic concentration beyond a critical point resulted in a transition from a burst-type profile to an extended-release profile. An interpretation of these results in terms of a qualitative model for the protein release mechanism is also given.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12490369     DOI: 10.1016/s0168-3659(02)00293-6

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  9 in total

1.  Effect of injection site on in situ implant formation and drug release in vivo.

Authors:  Ravi B Patel; Luis Solorio; Hanping Wu; Tianyi Krupka; Agata A Exner
Journal:  J Control Release       Date:  2010-08-20       Impact factor: 9.776

2.  The Effect of Additives on the Behavior of Phase Sensitive In Situ Forming Implants.

Authors:  Luis Solorio; Divya Sundarapandiyan; Alex Olear; Agata A Exner
Journal:  J Pharm Sci       Date:  2015-07-14       Impact factor: 3.534

Review 3.  Advances in image-guided intratumoral drug delivery techniques.

Authors:  Luis Solorio; Ravi B Patel; Hanping Wu; Tianyi Krupka; Agata A Exner
Journal:  Ther Deliv       Date:  2010-08

4.  Characterization of formulation parameters affecting low molecular weight drug release from in situ forming drug delivery systems.

Authors:  Ravi B Patel; Angela N Carlson; Luis Solorio; Agata A Exner
Journal:  J Biomed Mater Res A       Date:  2010-08       Impact factor: 4.396

5.  Effect of cargo properties on in situ forming implant behavior determined by noninvasive ultrasound imaging.

Authors:  Luis Solorio; Alexander M Olear; Haoyan Zhou; Ashlei C Beiswenger; Agata A Exner
Journal:  Drug Deliv Transl Res       Date:  2012-02-01       Impact factor: 4.617

6.  Effect of the Subcutaneous Environment on Phase-Sensitive In Situ-Forming Implant Drug Release, Degradation, and Microstructure.

Authors:  Luis Solorio; Agata A Exner
Journal:  J Pharm Sci       Date:  2015-10-27       Impact factor: 3.534

7.  Liquid-solid phase-inversion PLGA implant for the treatment of residual tumor tissue after HIFU ablation.

Authors:  Juan Li; Tianyi Krupka; Jinpeng Yao; Ronghui Wang; Lin Jiang; Yang Zhou; Guoqing Zuo; Zhibiao Wang; Lili Dai; Jianli Ren; Yuanyi Zheng; Dong Wang
Journal:  PLoS One       Date:  2015-02-24       Impact factor: 3.240

8.  An Optimized Surfactant-Based PEG-PLCL In Situ Gel Formulation For Enhanced Activity Of Rosuvastatin In Poloxamer-Induced Hyperlipidemic Rats.

Authors:  Tarek A Ahmed; Mohammed A Mussari; Seham El-Sayed Abdel-Hady; Khalid M El-Say
Journal:  Drug Des Devel Ther       Date:  2019-12-03       Impact factor: 4.162

9.  Noninvasive characterization of the effect of varying PLGA molecular weight blends on in situ forming implant behavior using ultrasound imaging.

Authors:  Luis Solorio; Alexander M Olear; Jesse I Hamilton; Ravi B Patel; Ashlei C Beiswenger; Jon E Wallace; Haoyan Zhou; Agata A Exner
Journal:  Theranostics       Date:  2012-11-08       Impact factor: 11.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.